Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CLELAND

Showing results (421-430 of 663) with videos related to

Pageof 67
Sort By:
Heart (British Cardiac Society)|February 26, 2014
Development of a composite model derived from cardiopulmonary exercise tests to predict mortality risk in patients with mild-to-moderate heart failureLee Ingle, Alan S Rigby, Rebecca Sloan, et al.
Rheumatology and Rehabilitation|November 1, 1982
Evaluation of a single daily dose of naproxen in osteoarthritisP M Brooks, L G Cleland, A L Haski, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Pulmonary and systemic responses to exogenous endothelin-1 in patients with left ventricular dysfunctionP J Cowburn, J G Cleland, J D McArthur, et al.
The Pharmacogenomics Journal|January 8, 2014
Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritisM D Wiese, N Alotaibi, C O'Doherty, et al.
European Journal of Heart Failure|August 11, 2000
Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival studyJ G Cleland, P Armstrong, J D Horowitz, et al.
The Medical Journal of Australia|January 29, 2016
Ten years of publicly funded biological disease-modifying antirheumatic drugs in AustraliaAshley M Hopkins, Susanna M Proudman, Agnes I Vitry, et al.
The British Journal of Nutrition|August 19, 2015
Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritisSusanna M Proudman, Leslie G Cleland, Robert G Metcalf, et al.
Heart (British Cardiac Society)|February 9, 2026
Association between body mass index, plasma N-terminal pro-B-type natriuretic peptide, symptoms and outcome in patients referred for investigation of suspected heart failureElton Luo, Joseph James Cuthbert, Syed Kazmi, et al.
BMJ (Clinical Research Ed.)|November 24, 1990
Unsuspected renal artery stenosis in peripheral vascular diseaseA H Choudhri, J G Cleland, P C Rowlands, et al.
Biochimica Et Biophysica Acta|October 19, 2006
Endothelial cell COX-2 expression and activity in hypoxiaRebecca J Cook-Johnson, Maryanne Demasi, Leslie G Cleland, et al.
Pageof 67

Showing results (421-430 of 663) with videos related to

Sort By:
Pageof 67
Heart (British Cardiac Society)|February 26, 2014
Development of a composite model derived from cardiopulmonary exercise tests to predict mortality risk in patients with mild-to-moderate heart failureLee Ingle, Alan S Rigby, Rebecca Sloan, et al.
Rheumatology and Rehabilitation|November 1, 1982
Evaluation of a single daily dose of naproxen in osteoarthritisP M Brooks, L G Cleland, A L Haski, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Pulmonary and systemic responses to exogenous endothelin-1 in patients with left ventricular dysfunctionP J Cowburn, J G Cleland, J D McArthur, et al.
The Pharmacogenomics Journal|January 8, 2014
Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritisM D Wiese, N Alotaibi, C O'Doherty, et al.
European Journal of Heart Failure|August 11, 2000
Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival studyJ G Cleland, P Armstrong, J D Horowitz, et al.
The Medical Journal of Australia|January 29, 2016
Ten years of publicly funded biological disease-modifying antirheumatic drugs in AustraliaAshley M Hopkins, Susanna M Proudman, Agnes I Vitry, et al.
The British Journal of Nutrition|August 19, 2015
Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritisSusanna M Proudman, Leslie G Cleland, Robert G Metcalf, et al.
Heart (British Cardiac Society)|February 9, 2026
Association between body mass index, plasma N-terminal pro-B-type natriuretic peptide, symptoms and outcome in patients referred for investigation of suspected heart failureElton Luo, Joseph James Cuthbert, Syed Kazmi, et al.
BMJ (Clinical Research Ed.)|November 24, 1990
Unsuspected renal artery stenosis in peripheral vascular diseaseA H Choudhri, J G Cleland, P C Rowlands, et al.
Biochimica Et Biophysica Acta|October 19, 2006
Endothelial cell COX-2 expression and activity in hypoxiaRebecca J Cook-Johnson, Maryanne Demasi, Leslie G Cleland, et al.
Pageof 67